AAVSTC-1,退

Yange Wang1, Siyu Li1, Chenxu Zhang1

  • 1Department of Ophthalmology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Henan Eye Hospital and Henan Key Laboratory of Ophthalmology and Visual Science, Zhengzhou, 450003, China.

PubMed
概括

斯坦尼奥卡尔辛-1 (STC-1) 基因疗法在治疗视网膜退化 (RD) 方面表现有前途. 在小鼠模型中,过度表达STC-1保留了视网膜结构,并通过减少炎症和氧化应激来改善视力.